Related Experiment Videos
[Bronchial cancer--adjuvant chemotherapy]
1Thoraxklinik der LVA Baden, Heidelberg.
Langenbecks Archiv Fur Chirurgie. Supplement II, Verhandlungen Der Deutschen Gesellschaft Fur Chirurgie. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1990
Abstract:
Lung cancer patients with poor late prognosis should receive adjuvant chemotherapy. Its application in non-small cell lung cancer (NSCLC) is only justified in clinical studies, since there is no evidence of its efficacy. In small cell lung cancer (SCLC) chemotherapy is supplemented by local therapy regimens like radiotherapy and/or surgery. At present clinical studies are examining whether chemotherapy should be applied before or after surgical treatment.